Tellus Therapeutics Funding: $35M Raised, Series A (2022)
Tellus Therapeutics is based in Durham, NC. It has raised $35M in total funding. Latest round: Series A.
Tellus Therapeutics funding overview
Tellus Therapeutics is based in Durham, NC. Tellus Therapeutics has raised $35M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2022. The round record for Tellus Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Xontogeny, Perceptive Xontogeny Venture Fund, Perceptive Advisors. 3 distinct backers are named across the disclosed rounds.
Frequently asked about Tellus Therapeutics funding
How much has Tellus Therapeutics raised?
Tellus Therapeutics has raised $35M in total disclosed funding across the rounds on record.
Who has invested in Tellus Therapeutics?
Xontogeny, Perceptive Xontogeny Venture Fund, Perceptive Advisors are named among the investors backing Tellus Therapeutics.
What was the latest Tellus Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2022.
Where is Tellus Therapeutics based?
Tellus Therapeutics is based in Durham, NC.
When did Tellus Therapeutics last raise?
The last disclosed Tellus Therapeutics round closed in December 2022 at Series A.
We update the Tellus Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Durham and their backers are listed below.
